Home › Thoracic Cancer › District of Columbia
Thoracic Cancer clinical trials in District of Columbia
3 studies for Thoracic Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1001, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07407933A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Erector Spinae Block for Thoracic Surgery
- The George Washington University, Washington D.C.
RecruitingPhase 4
Ages 18 to 90 · All sexes · Updated Feb 25, 2026 · NCT05521789From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.